These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 104609)

  • 1. Prolonged hemodynamic effects (12 hours) of orally administered sustained-release nitroglycerin.
    Strumza P; Rigaud M; Mechmeche R; Rocha P; Baudet M; Bardet J; Bourdarias JP
    Am J Cardiol; 1979 Feb; 43(2):272-7. PubMed ID: 104609
    [No Abstract]   [Full Text] [Related]  

  • 2. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral hemodynamic effects of oral controlled-release nitroglycerin (Nitrong) in man.
    Hirshleifer I
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):158-64. PubMed ID: 4633276
    [No Abstract]   [Full Text] [Related]  

  • 4. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.
    Jordan RA; Seth L; Casebolt P; Hayes MJ; Wilen MM; Franciosa J
    Ann Intern Med; 1986 Mar; 104(3):295-8. PubMed ID: 3080935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide angiography: noninvasive assessment of hemodynamic changes after administration of nitroglycerin.
    Ritchie JL; Sorensen S; Kennedy JW; Hamilton GW
    Am J Cardiol; 1979 Feb; 43(2):278-84. PubMed ID: 104610
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failure.
    Natarajan D; Khurana TR; Karhade V; Nigam PD
    Am J Cardiol; 1988 Aug; 62(4):319-21. PubMed ID: 3135741
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure.
    Amsterdam EA; Awan NA; DeMaria AN; Miller RR; Williams DO; Mason DT
    Clin Cardiol; 1979 Feb; 2(1):19-25. PubMed ID: 115631
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects of nitroglycerin in oral form (Nitrilex Spray)].
    Stejfa M; Vítovec J; Roubalík P; Blaha M
    Vnitr Lek; 1988 Mar; 34(3):237-44. PubMed ID: 3130719
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
    Roth A; Kulick D; Freidenberger L; Hong R; Rahimtoola SH; Elkayam U
    J Am Coll Cardiol; 1987 Apr; 9(4):858-64. PubMed ID: 3104435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
    Packer M; Lee WH; Kessler PD; Gottlieb SS; Medina N; Yushak M
    N Engl J Med; 1987 Sep; 317(13):799-804. PubMed ID: 3114637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M; Lee WH
    Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.
    Willis WH; Russell RO; Mantle JA; Ratshin RA; Rackley CE
    Chest; 1976 Jan; 69(1):15-22. PubMed ID: 811427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a sustained-release buccal nitroglycerin preparation in stable angina pectoris.
    Grasso S; Pesciatini F; Ugolini C; Lepore R; Cerri B
    Int J Clin Pharmacol Res; 1988; 8(2):131-7. PubMed ID: 3132428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity: a double-blind evaluation.
    Davidov ME; Mroczek WJ
    Angiology; 1977 Mar; 28(3):181-9. PubMed ID: 405891
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
    Armstrong PW
    J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical usefulness of a transdermal nitroglycerin patch as a sustained vasodilator for patients with heart failure].
    Hirosawa K; Sekiguchi M; Hiroe M; Honda T; Matsumoto N; Yasuda H; Kanazawa T; Miura M; Hayakawa H; Takano T
    Kokyu To Junkan; 1987 Mar; 35(3):305-15. PubMed ID: 3108982
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure.
    Dupuis J; Lalonde G; Lebeau R; Bichet D; Rouleau JL
    Am Heart J; 1990 Sep; 120(3):625-37. PubMed ID: 2117845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vasodilators, oral nitrate derivatives and treatment of heart failure].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(2):139-46. PubMed ID: 825345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.